Oncology & Cancer

Germany's BioNTech plans UK trial of mRNA cancer therapy

German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.

Diseases, Conditions, Syndromes

Nasal vaccine to prevent COVID-19 passes first tests

Coronaviruses spread primarily through the air. When infected people speak, cough, sneeze or laugh, they expel droplets of saliva containing the virus. Other people then breathe in these airborne pathogens and become infected ...

Oncology & Cancer

Enhanced melanoma vaccine offers improved survival for men

A second-generation melanoma vaccine being developed at UVA Cancer Center improves long-term survival for melanoma patients compared with the first-generation vaccine, new research shows. Interestingly, the benefit of the ...

page 9 from 40